Fig. 4From: Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolatesAntimicrobial screening of the formulated imipenem/cilastatin loaded polycaprolactone (IMP/PCL) and imipenem/cilastatin loaded polylactide-co-glycolide (IMP/PLGA) nanoparticles against Klebsiella pneumoniae, KMU5.5 (a) and Pseudomonas aeruginosa PUMU2.3 (b) compared to imipenem/cilastatin (IMP). IMP/PCL retained antimicrobial activity against both isolatesBack to article page